October 19, 2017
#NORDsummit – Despite Criticism, Orphan Drug Act Is Working to Advance Needed Treatments, FDA Says

As Congress begins debate this week to overhaul the U.S. tax code, lawmakers should leave the Orphan Drug Act ... Read more
October 18, 2017October 18, 2017
Enbrel Treatment Leads to Early Reparative Response in Patients with Non-Radiographic Axial Spondyloarthritis

Patients with non-radiographic axial spondyloarthritis (nr-axSpA) treated with Amgen‘s Enbrel (etanercept), which blocks tumor necrosis factor (TNF), experience a ... Read more
October 4, 2017October 4, 2017
CreakyJoints Releases Guide, Made by Patients, Reviewed by Rheumatologists

CreakyJoints has released a guide for people living with ankylosing spondylitis, the first to be developed by patients and ... Read more
October 2, 2017October 2, 2017
Taiwanese Study Links Ankylosing Spondylitis to Higher Risk of Certain Cancers

Ankylosing spondylitis (AS) patients must be screened for certain cancers due to their higher risk, a study from Taiwan ... Read more
September 25, 2017September 25, 2017
MEFV Gene Mutation May Make People More Susceptible to Developing AS, Study Indicates

A meta-analysis of studies on ankylosing spondylitis found a link between a mutation in the Mediterranean fever (MEFV) gene ... Read more
September 20, 2017September 20, 2017
Xeljanz Shows Promise for Ankylosing Spondylitis in Phase 2 Trial

Xeljanz (tofacitinib) showed promising results for ankylosing spondylitis (AS) patients in a 16-week Phase 2 clinical trial. AS patients ... Read more
September 18, 2017September 18, 2017
Cyltezo, a Humira Biosimilar, Receives Positive Opinion from European CHMP

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for ... Read more
September 13, 2017September 13, 2017
Low BMI in Axial Spondyloarthritis Patients Linked to Weaker Bones, Study Suggests

After analyzing 80 axial spondyloarthritis (axSpA) patients, a French research team found a lower bone mineral density (BMD, or weaker bones) ... Read more
September 11, 2017September 11, 2017
Axial Spondyloarthritis Patients Who are Obese Don’t Do as Well on TNF Blockers, Study Reports

Obese patients with axial spondyloarthritis are less likely to respond to treatment with TNF blockers than ... Read more
September 6, 2017September 6, 2017
Patients with Chronic Inflammatory Disorders at Greater Risk for Heart Disease, Diabetes, Study Finds

Patients with chronic inflammatory disorders, including ankylosing spondylitis, are at a higher risk of experiencing multiple cardiometabolic events than ... Read more
September 1, 2017September 1, 2017
E.U. Approves Imraldi, a Humira Biosimilar, for Ankylosing Spondylitis, Other Inflammatory Diseases

The European Commission recently granted a marketing authorization for Imraldi, a biosimilar approved to treat the same inflammatory diseases ... Read more
August 28, 2017August 28, 2017
Canada Approves Etanercept Biosimilar Erelzi for Treatment of Ankylosing Spondylitis

Health Canada has approved Sandoz’s Erelzi, a biosimilar therapy of etanercept, for the treatment of ankylosing ... Read more

#NORDsummit – Despite Criticism, Orphan Drug Act Is Working to Advance Needed Treatments, FDA Says

As Congress begins debate this week to overhaul the U.S. tax code, lawmakers should leave the Orphan Drug Act (ODA) — and the tax incentives it offers pharmaceutical companies ... Read more

October 18, 2017October 18, 2017

Enbrel Treatment Leads to Early Reparative Response in Patients with Non-Radiographic Axial Spondyloarthritis

Patients with non-radiographic axial spondyloarthritis (nr-axSpA) treated with Amgen‘s Enbrel (etanercept), which blocks tumor necrosis factor (TNF), experience a very early reparative response to therapy, new research shows. The ... Read more

October 4, 2017October 4, 2017

CreakyJoints Releases Guide, Made by Patients, Reviewed by Rheumatologists

CreakyJoints has released a guide for people living with ankylosing spondylitis, the first to be developed by patients and reviewed by rheumatologists. “A Patient’s Guide to Living with Ankylosing ... Read more

October 2, 2017October 2, 2017

Taiwanese Study Links Ankylosing Spondylitis to Higher Risk of Certain Cancers

Ankylosing spondylitis (AS) patients must be screened for certain cancers due to their higher risk, a study from Taiwan warns. The study, “Ankylosing spondylitis and the risk of cancer,” ... Read more

September 25, 2017September 25, 2017

MEFV Gene Mutation May Make People More Susceptible to Developing AS, Study Indicates

A meta-analysis of studies on ankylosing spondylitis found a link between a mutation in the Mediterranean fever (MEFV) gene and AS. AS is a chronic inflammatory disease that is ... Read more

September 20, 2017September 20, 2017

Xeljanz Shows Promise for Ankylosing Spondylitis in Phase 2 Trial

Xeljanz (tofacitinib) showed promising results for ankylosing spondylitis (AS) patients in a 16-week Phase 2 clinical trial. AS patients with active disease receiving Xeljanz treatment showed great improvement in symptoms ... Read more

September 18, 2017September 18, 2017

Cyltezo, a Humira Biosimilar, Receives Positive Opinion from European CHMP

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Cyltezo, a Humira (adalimumab) biosimilar, for the treatment of multiple ... Read more

September 13, 2017September 13, 2017

Low BMI in Axial Spondyloarthritis Patients Linked to Weaker Bones, Study Suggests

After analyzing 80 axial spondyloarthritis (axSpA) patients, a French research team found a lower bone mineral density (BMD, or weaker bones) among those who also have a lower body mass index ... Read more

September 11, 2017September 11, 2017

Axial Spondyloarthritis Patients Who are Obese Don’t Do as Well on TNF Blockers, Study Reports

Obese patients with axial spondyloarthritis are less likely to respond to treatment with TNF blockers than patients at a healthy weight, according to a study suggesting that weight loss ... Read more

September 6, 2017September 6, 2017

Patients with Chronic Inflammatory Disorders at Greater Risk for Heart Disease, Diabetes, Study Finds

Patients with chronic inflammatory disorders, including ankylosing spondylitis, are at a higher risk of experiencing multiple cardiometabolic events than matching controls with no inflammatory disease. The risk was almost ... Read more